✦ LIBER ✦

Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells

✍ Scribed by Benjamin Bonavida; Toshiharu Tsuchitani; Jacob Zighelboim; Jonathan S. Berek

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergy is documented in vitro with low-

✍ B Bonavida; T Tsuchitani; J Zighelboim; JS Berek 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Synergistic activity in vitro of low-dos

✍ M. Dudzinski; M. Ketting; M. Chun; W. McGuire; J. Currie 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Synergistic antitumor effect of tumor ne

✍ P. LIU; H. MAO; P. HOU 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 986 KB

In vitro growth inhibition of cisplatin-

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 152 KB